Platinum Priority – Brief CorrespondenceEditorial by Andrea Minervini , Riccardo Campi, Alberto Lapini and Marco Carini on pp. 175–176 of this issueComplications After Metastasectomy for Renal Cell Carcinoma—A Population-based Assessment☆
References (9)
- et al.
Metastasectomy after targeted therapy in patients with advanced renal cell carcinoma
J Urol
(2011) - et al.
A multi-institution analysis of outcomes of liver-directed surgery for metastatic renal cell cancer
HPB
(2012) - et al.
Safety of presurgical targeted therapy in the setting of metastatic renal cell carcinoma
Eur Urol
(2011) - et al.
Complications and outcomes associated with surgical management of renal cell carcinoma involving the liver: a matched cohort study
Urology
(2017)
Cited by (45)
Role of Surgery in Metastatic Renal Cell Carcinoma
2023, Hematology/Oncology Clinics of North AmericaStereotactic Ablative Radiation (SAbR) for Oligometastatic RCC
2021, Seminars in Radiation OncologyCitation Excerpt :One population-based assessment of 1102 mRCC patients who underwent metastasectomy reported an overall complication rate of 45.7%, with major complications constituting 27.5% of procedures. Resections of hepatic lesions were significantly associated with higher odds of overall complications compared with any other site.30 Despite high local control after metastasectomy, most surgically treated patients ultimately develop systemic recurrence.
A drug delivery perspective on intratumoral-immunotherapy in renal cell carcinoma
2021, Urologic Oncology: Seminars and Original InvestigationsThe Evolving Role of Metastasectomy for Patients with Metastatic Renal Cell Carcinoma
2020, Urologic Clinics of North AmericaCitation Excerpt :Alternatively, higher-volume centers may be more likely to publish data for metastasectomy,16 which may be skewed because of better outcomes demonstrated at centers with higher volume of mRCC patients.71 Age, comorbidities, and hepatic surgery are associated with higher risk of major complications.69 Alternatives to surgical metastasectomy include radiation and thermal ablation.
Predictive factors for recurrence after complete metastasectomy in patients with metastatic renal cell carcinoma in the targeted therapy era
2020, Urologic Oncology: Seminars and Original InvestigationsCitation Excerpt :They investigated 45,279 patients with mRCC who underwent metastasectomy and showed that overall and major (Clavien-Dindo 3–4) complications occurred in 45.7% and 25.1% of patients, respectively, and the in-hospital mortality rate was 2.4%. In addition, predictors for major complications were a high comorbidity burden, and resections of hepatic lesions were significantly associated with higher odds of overall complications compared with other sites [11]. Therefore, indication for metastasectomy should be carefully considered.
- ☆
Please visit www.eu-acme.org/europeanurology to read and answer questions on-line. The EU-ACME credits will then be attributed automatically.
- 1
These authors contributed equally.